Drugs Made In Stock Market Value
| DMAAU Stock | 10.44 0.04 0.38% |
| Symbol | Drugs |
Drugs Made In Company Valuation
Is Trading space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 04/25/2025 |
| 07/24/2025 |
If you would invest 0.00 in Drugs Made on April 25, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with Nexstar Broadcasting, Grupo Aeroportuario, Mayfair Gold, Corsair Gaming, Delta Air, United Parks, and Mattel. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.91 | |||
| Information Ratio | (0.36) | |||
| Maximum Drawdown | 4.04 | |||
| Value At Risk | (0.77) | |||
| Potential Upside | 0.7752 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.0756 | |||
| Jensen Alpha | 0.0373 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | (0.19) | |||
| Treynor Ratio | (3.64) |
Drugs Made In Backtested Returns
Currently, Drugs Made In is very steady. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.0886, which denotes the company had a 0.0886 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Mean Deviation of 0.2478, downside deviation of 0.91, and Coefficient Of Variation of 1058.14 to check if the risk estimate we provide is consistent with the expected return of 0.0442%. Drugs Made has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0097, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Drugs Made are expected to decrease at a much lower rate. During the bear market, Drugs Made is likely to outperform the market. Drugs Made In right now shows a risk of 0.5%. Please confirm Drugs Made In skewness, and the relationship between the value at risk and day median price , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.37 |
Below average predictability
Drugs Made In has below average predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 25th of April 2025 to 9th of June 2025 and 9th of June 2025 to 24th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Drugs Made In lagged returns against current returns
Autocorrelation, which is Drugs Made stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Drugs Made's stock expected returns. We can calculate the autocorrelation of Drugs Made returns to help us make a trade decision. For example, suppose you find that Drugs Made has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Drugs Made regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Drugs Made stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Drugs Made stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Drugs Made stock over time.
Current vs Lagged Prices |
| Timeline |
Drugs Made Lagged Returns
When evaluating Drugs Made's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Drugs Made stock have on its future price. Drugs Made autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Drugs Made autocorrelation shows the relationship between Drugs Made stock current value and its past values and can show if there is a momentum factor associated with investing in Drugs Made In.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Drugs Stock Analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.